Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy

• Status: NOT_YET_RECRUITING
• Trial end date: 2028-06-30

Summary

Hepatitis C is a common and potentially serious disease. However, there are treatments that can cure it. That's why it's so important to detect the hepatitis C virus (HCV) and treat those affected. Today, many hepatitis C sufferers in Cameroon (and elsewhere) remain untreated.

The aim of this research is therefore to evaluate a simplified screening and treatment strategy (developed specifically for the Cameroonian context) in comparison with a standard strategy (based on usual care), in order to improve access to hepatitis C treatment in Cameroon. If the results of this research are positive, this strategy could be recommended to health authorities in Cameroon and other comparable countries.

• Phase: PHASE4

Details

• Lead Sponsor: ANRS, Emerging Infectious Diseases
• Collaborators: Centre de Recherche sur les Maladies Emergentes et Re-Emergentes (CREMER); Facult de Mdecine et des Sciences Biomdicales, Universit de Yaound I, Yaound, Cameroun; IRD, Epidemiologie et Prevention, Montpelier, France; PharmAccess; Service d'hpato-gastroentrologie, Hpital Saint Joseph, Marseille, France; SESSTIM (IRD, Inserm, Universit Aix-Marseille)